Renal Mass Biopsy to Guide Treatment Decisions for Small Incidental Renal Tumors: A Cost-effectiveness Analysis
Authors:
- Pari V. PandharipandePPPari V. Pandharipande
- Debra A. GervaisDGDebra A. Gervais
- Rebecca I. HartmanRHRebecca I. Hartman
- Mukesh G. HarisinghaniMHMukesh G. Harisinghani
- Adam S. FeldmanAFAdam S. Feldman
- Peter R. MuellerPMPeter R. Mueller
- G. Scott GazelleGGG. Scott Gazelle
- 1 September 2010
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 256 (3) , 836-846
Abstract
Our results support the use of biopsy to manage small incidentally detected renal tumors. PurposeTo evaluate the effectiveness, cost, and cost-effectiveness of using renal mass biopsy to guide treatment decisions for small incidentally detected renal tumors.Materials and MethodsA decision-analytic Markov model was developed to estimate life expectancy and lifetime costs for patients with small (≤4-cm) renal tumors. Two strategies were compared: renal mass biopsy to triage patients to surgery or imaging surveillance and empiric nephron-sparing surgery. The model incorporated biopsy performance, the probability of track seeding with malignant cells, the prevalence and growth of benign and malignant tumors, treatment effectiveness and costs, and patient outcomes. An incremental cost-effectiveness analysis was performed to identify strategy preference under a willingness-to-pay threshold of $75 000 per quality-adjusted life-year (QALY). Effects of changes in key parameters on strategy preference were evaluated in sensitivity analysis.ResultsUnder base-case assumptions, the biopsy strategy yielded ...Keywords
This publication has 68 references indexed in Scilit:
- Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillanceCancer, 2009
- Cryoablation or radiofrequency ablation of the small renal massCancer, 2008
- Pathological Features of Renal Neoplasms Classified by Size and SymptomatologyJournal of Urology, 2006
- Rising Incidence of Small Renal Masses: A Need to Reassess Treatment EffectJNCI: Journal of the National Cancer Institute, 2006
- Willingness to Pay for a QALYPharmacoEconomics, 2005
- Evaluation of Patients Referred for Percutaneous Ablation of Renal Tumors: Importance of a Preprocedural DiagnosisAmerican Journal of Roentgenology, 2004
- Evaluation of Sonographically Guided Percutaneous Core Biopsy of Renal MassesAmerican Journal of Roentgenology, 2002
- NEPHRON SPARING SURGERY FOR RENAL TUMORS: INDICATIONS, TECHNIQUES AND OUTCOMESJournal of Urology, 2001
- Willingness to Pay for a Quality-adjusted Life YearMedical Decision Making, 2000
- Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy.American Journal of Roentgenology, 1993